[(2R,3R,4S,5S,6R)-5-butanoyloxy-3,4-di(hexanoyloxy)-6-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexoxy]tetrahydropyran-2-yl]methyl hexanoate

ID: ALA4777903

PubChem CID: 162644231

Max Phase: Preclinical

Molecular Formula: C34H60O15

Molecular Weight: 708.84

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCCC(=O)OC[C@H]1O[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCCCC)[C@@H]1OC(=O)CCCCC

Standard InChI:  InChI=1S/C34H60O15/c1-5-9-12-16-25(38)44-21-24-31(47-27(40)17-13-10-6-2)32(48-28(41)18-14-11-7-3)33(49-26(39)15-8-4)34(46-24)45-20-23(37)30(43)29(42)22(36)19-35/h22-24,29-37,42-43H,5-21H2,1-4H3/t22-,23-,24-,29-,30-,31-,32+,33+,34-/m1/s1

Standard InChI Key:  QXSHEWNKUZTVMG-ATPGFXIISA-N

Molfile:  

 
     RDKit          2D

 49 49  0  0  0  0  0  0  0  0999 V2000
   19.8850   -3.9044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8850   -4.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5944   -5.1301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3038   -4.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3038   -3.9044    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5944   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0150   -5.1353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5944   -5.9515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1737   -5.1353    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5944   -2.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1720   -3.4937    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3062   -2.2576    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0159   -5.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7241   -6.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7249   -7.1775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4331   -7.5854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4340   -8.4025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4313   -5.9510    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0177   -7.5869    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1404   -7.1760    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1421   -8.8104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1430   -9.6276    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7267   -8.8119    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0129   -2.6680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7216   -2.2612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0109   -3.4852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4283   -2.6715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1711   -2.6765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4629   -2.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8783   -2.2672    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7557   -2.6780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4665   -4.7259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7583   -5.1338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4673   -3.9088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.0511   -4.7244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8867   -6.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8867   -7.1773    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1790   -5.9515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4713   -6.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1371   -2.2647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0475   -2.2702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3429   -5.1323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8437   -2.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3402   -2.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6356   -4.7229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5525   -2.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6321   -2.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6365   -3.9057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4713   -7.1773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  1
  3  8  1  1
  2  9  1  1
  6 10  1  1
  1 11  1  6
 10 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 18  1  1
 15 19  1  6
 16 20  1  6
 17 21  1  0
 21 22  1  0
 17 23  1  1
 12 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 11 28  1  0
 28 29  1  0
 28 30  2  0
 29 31  1  0
  9 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  1  0
  8 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 27 40  1  0
 31 41  1  0
 35 42  1  0
 40 43  1  0
 41 44  1  0
 42 45  1  0
 43 46  1  0
 44 47  1  0
 45 48  1  0
 39 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777903

    ---

Associated Targets(non-human)

Schizosaccharomyces pombe (495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 708.84Molecular Weight (Monoisotopic): 708.3932AlogP: 1.98#Rotatable Bonds: 26
Polar Surface Area: 224.81Molecular Species: NEUTRALHBA: 15HBD: 5
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.59CX Basic pKa: CX LogP: 3.51CX LogD: 3.51
Aromatic Rings: Heavy Atoms: 49QED Weighted: 0.05Np Likeness Score: 1.10

References

1. Tsutsui N,Tanabe G,Ikeda N,Okamura S,Ogawa M,Miyazaki K,Kita A,Sugiura R,Muraoka O.  (2016)  Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 4: Role of acyl side chains on d-mannose.,  121  [PMID:27243802] [10.1016/j.ejmech.2016.05.034]

Source